Tempus AI, Inc. (NASDAQ:TEM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 22, 2025, that ...

Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14, 2024, and it ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Tempus AI and Hims & Hers are riding healthcare IT growth, but diagnostics scale and consumer demand set different upside paths.

A significant technology, Transmission electron microscopy (TEM) has found its way into cell biology since 1940. When compared with light microscopes, TEM can achieve a very high resolution due to the ...

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM provides next generation sequencing diagnostics, polymerase chain reaction ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Tempus AI, Inc. stands third on our list among the most promising stocks. TheFly reported on December 15 ...

Tempus AI has EV/forward revenue under 10x, positive EBITDA, 33% genomics growth, and $150M in new contracts. Find out why ...

Transmission Electron Microscopy (TEM) and Scanning Electron Microscopy (SEM) are widely considered the gold standard for nanoparticle characterization. However, choosing which to employ is a complex ...

In this process, the particle to be studied is exposed to electron beams under a high-resolution microscope called a transmission electron microscope and the micrographs or images captured are ...